19.09.2023: Annual Report For 2022-23 is available
15.02.2023: Q3 22-23 ENGLISH AD - Audited Financial Results
15.02.2023: Q3 22-23 TELUGU AD - Audited Financial Results
15.11.2022: Q2 22-23 ENGLISH AD - Audited Financial Results
15.11.2022: Q2 22-23 TELUGU AD - Audited Financial Results
19.10.2022: Retirement of G Venkata Ramana
15.08.2022: Q1 22-23 ENGLISH AD - Audited Financial Results
15.08.2022: Q1 22-23 TELUGU AD - Audited Financial Results
29.11.2021: Demise of Mohan Krishna Murthy Whole time Director of the Company - 26-11-2021
14.09.2021: Extension of Annual General Meeting for the Financial year 2020-21
01-07-2021: Closure of Trading Window
30.06.2021: Adjournment of the Board meeting held on 30.06.2021
19.01.2021: Allotment of shares pursuant to the Scheme of Arrangement - 2021
11-01-2021: Updated final order and scheme related details - National Company Law Tribunal .
01.01.2021: Outcome of Board Meeting held on 01.01.2021
29-12-2020: Updated registers.
05.12.2020: Outcome of board meeting under Regulation 30 of SEBI
12-03-2020: Final results of the demerger are updated.
21-06-2019: Demerger process has been approved by BSE & NSE. Copies of approval letters have been updated.
02-07-2018: Revised scheme of arrangement
06-09-2017: Access documents related to the scheme of demerger between Ortin Laboratories LTD & Vineet Laboratories LTD